What is the differential diagnosis for an expansile, T2‑hyperintense, non‑enhancing spinal cord lesion?

Differential Diagnosis for Expansile, T2-Hyperintense, Non-Enhancing Spinal Cord Lesion

The differential diagnosis for an expansile, T2-hyperintense, non-enhancing spinal cord lesion includes astrocytoma (particularly low-grade), ependymoma (though these often enhance), syrinx/syringomyelia, demyelinating disease (especially tumefactive demyelination), and less commonly MVNT-like lesions or chronic ischemia.

Algorithmic Approach to Diagnosis

Step 1: Assess Temporal Characteristics

• Acute onset (days to weeks): Consider demyelinating disease, inflammatory myelitis, or vascular causes
• Subacute to chronic (weeks to months): Consider neoplasm (astrocytoma, ependymoma), syrinx, or chronic inflammatory conditions 1

Step 2: Evaluate Cord Expansion Pattern

The presence of cord expansion is critical:

• Focal expansion with mass effect: Strongly suggests intramedullary tumor (astrocytoma most likely given lack of enhancement) 1, 2
• Diffuse expansion: Consider inflammatory/demyelinating disease or infiltrative tumor
• Minimal/no expansion: Consider syrinx, MVNT-like lesion, or tract-based degeneration 3

Step 3: Analyze T2 Signal Pattern and Distribution

Gray vs. White Matter Involvement 4:

• Central gray matter predominance: Vascular causes (anterior spinal artery syndrome), inflammatory conditions
• White matter predominance: Demyelinating disease, tract degeneration
• Both gray and white matter: Neoplasm, extensive inflammatory disease

Longitudinal Extent 1, 2:

• Short segment (<2 vertebral bodies): Neoplasm, focal inflammatory lesion
• Longitudinally extensive (≥3 vertebral bodies): Demyelinating disease (neuromyelitis optica spectrum disorder, MS), inflammatory myelitis, or infiltrative astrocytoma

Step 4: Look for Associated Features

Critical imaging clues 1, 4:

• Cystic/syrinx formation: Suggests post-traumatic syrinx, tumor-associated cyst, or non-neoplastic lesion 5
• Multiple nodular lesions: MVNT-like spinal cord lesions (rare, typically incidental) 3
• Hemosiderin rim: Would suggest cavernous malformation (though these typically enhance and have characteristic "popcorn" appearance) 6
• Associated brain lesions: Demyelinating disease, metastatic disease

Step 5: Integrate Clinical Context

Age considerations:

• Pediatric/young adult: Astrocytoma (most common intramedullary tumor in children), demyelinating disease
• Middle-aged adult: Ependymoma, demyelinating disease, astrocytoma
• Elderly: Degenerative changes, ischemia, less commonly tumor

Symptom progression:

• Rapid progression: Inflammatory/demyelinating disease, high-grade tumor (though these usually enhance)
• Slow, insidious progression: Low-grade astrocytoma, syrinx, chronic inflammatory conditions

Key Differential Diagnoses

1. Low-Grade Astrocytoma

• Most common primary intramedullary tumor
• Typically expansile, T2-hyperintense
• May not enhance, especially low-grade variants
• Often spans multiple segments
• Associated cyst formation common 5

2. Syrinx/Syringomyelia

• Well-defined, CSF-intensity cavity
• Typically non-expansile or minimally expansile
• No enhancement
• May be post-traumatic, associated with Chiari malformation, or tumor-related 5

3. Demyelinating Disease

• Can be expansile in acute/tumefactive phase
• Typically longitudinally extensive
• Lack of enhancement suggests chronic/inactive phase or specific entities like MS tract degeneration 7
• Look for periplaque or tract-based T2 hyperintensity 7

4. Ependymoma

• Caveat: Most ependymomas enhance, but small or low-grade variants may show minimal enhancement
• Central location (arising from central canal)
• Hemosiderin cap sign (when present)

5. MVNT-like Spinal Cord Lesions

• Rare entity recently described
• Multiple well-delineated non-enhancing T2-hyperintense cystic nodules
• Typically incidental, stable over time
• No associated symptoms 3

Critical Pitfalls to Avoid

1. Don't assume all non-enhancing lesions are benign: Low-grade astrocytomas can be infiltrative and progressive despite lack of enhancement 5

2. Lack of enhancement doesn't exclude tumor: Enhancement patterns vary with tumor grade, vascularity, and blood-spinal cord barrier integrity 8

3. Subtle lesions on clinical MRI: The evidence shows that 7T MRI detects significantly more pathology than clinical 1.5T imaging, with only 43% of lesions detected on sagittal clinical sequences 7. Consider advanced imaging if clinical suspicion remains high.

4. T2 hyperintensity alone is nonspecific: Must integrate morphology, distribution, clinical timeline, and associated features 1, 2, 4

5. Serial imaging is essential: Stability over 3-6 months favors benign entities (syrinx, MVNT-like lesions), while growth suggests neoplasm or active inflammatory disease 3

Recommended Next Steps

• Obtain complete spine imaging to assess for additional lesions (multifocal suggests demyelinating disease)
• Brain MRI to evaluate for supratentorial lesions (demyelinating disease, metastases)
• Laboratory workup: CSF analysis (oligoclonal bands, cells, protein), serum inflammatory markers, NMO-IgG/AQP4 antibodies if demyelinating disease suspected
• Short-interval follow-up MRI (3 months) to assess stability vs. progression
• Consider biopsy if diagnosis remains uncertain and lesion is progressive, as histopathology may be necessary to distinguish tumor from inflammatory conditions 8